Archive - April 2018
Akorn attempts to stop Fresenius from backing out of $4.3B takeover deal
FDA rejects Pfizer’s Herceptin biosimilar
New centre aims to Catapult UK into cell and gene therapy lead
Merck preps regulatory filings for much-needed antibiotic combo
Data integrity scuppers Fresenius deal with Akorn
Ministers write letter to Vertex over Orkambi debate
Fresenius pulls out of $4.3bn Akorn merger
Allergan declines to bid on Shire
